Toxicity OF Fluoropyrimidines: A Comparative Study of the Cardiotoxicity of capEcitabine and tEysuno
Phase of Trial: Phase II
Latest Information Update: 04 Jun 2019
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Capecitabine; Oxaliplatin
- Indications Biliary cancer; Colorectal cancer; Gastric cancer; Liver cancer; Oesophageal cancer; Pancreatic cancer
- Focus Adverse reactions
- Acronyms TOFFEE
- 05 Jun 2017 Planned End Date changed from 30 Dec 2017 to 31 Dec 2018.
- 05 Jun 2017 Planned primary completion date changed from 1 Aug 2015 to 31 Dec 2018.
- 09 Dec 2015 Planned End Date changed from 5 Jan 2015 to 30 Dec 2017 as reported by United Kingdom Clinical Research Network record.